| GILD Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the GILD shares outstanding history going back to 2/19/2010:
Also see: GILD Market Cap History GILD YTD Return |
GILD Shares Outstanding History — Gilead Sciences Share Count Over Time
As of 4/30/2026 Gilead Sciences has 1.24 billion GILD shares outstanding. Investors often track the GILD shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows GILD share count trends over time, with 68 historical shares outstanding datapoints presented, dating back to 2/19/2010.
| GILD Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GILD Historical Shares Outstanding: -2.29% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GILD Stock Price Chart |
| About Gilead Sciences Inc |
| Gilead Sciences is a biopharmaceutical company focused on advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Co. emphasizes the discovery, development, and commercialization of medicines for unmet medical needs. Its marketed products include AmBisome, Atripla, Biktarvy, Descovy (including for PrEP), Epclusa, Genvoya, Harvoni, Sovaldi, Truvada (including for PrEP), Veklury, Vemlidy, Viread, Yescarta, and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Domvanalimab, Zimberelimab, and Seladelpar for treating primary biliary cholangitis (PBC). Co. operates in over 35 countries. We show 68 historical shares outstanding datapoints in our coverage of GILD's shares outstanding history. Understanding the changing numbers of GILD shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like GILD versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching GILD by allowing them to research GILD shares outstanding history as well as any other stock in our coverage universe. |
| GILD Current Stock Quote |
Quotes delayed 20 minutes  Free GILD Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| GILD Share Performance |
| Shares Outstanding Peers |
| Gilead Sciences (GILD) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
GKOS Shares Outstanding History GLSI Shares Outstanding History GLTO Shares Outstanding History GLUE Shares Outstanding History GLXY Shares Outstanding History GLYC Shares Outstanding History GMED Shares Outstanding History GMTX Shares Outstanding History GNCA Shares Outstanding History GNLX Shares Outstanding History More Healthcare companies » |
GILD Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
